MSS
IBB icon

Mitchell Sinkler & Starr’s iShares Biotechnology ETF IBB Stock Holding History

Mitchell Sinkler & Starr’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-643
Closed -$85K – 159
2024
Q4 		$85K Hold
643
– – 0.02% 170
2024
Q3 		$93.6K Hold
643
– – 0.02% 171
2024
Q2 		$92.7K Hold
643
– – 0.02% 165
2024
Q1 		$88.2K Buy
643
+25
+4% +$3.41K 0.02% 166
2023
Q4 		$84K Buy
+618
New +$75.4K 0.02% 182

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
MMEA
Main Management ETF Advisors San Francisco, California $2.68B AUM 24.27% 1-Year Est. Return

Mitchell Sinkler & Starr's IBB Position: Q1 2025 in Review

Mitchell Sinkler & Starr sold out of iShares Biotechnology ETF (IBB) in Q1 2025, closing a stake of 643 shares — an estimated $85K sold.

Mitchell Sinkler & Starr first reported a position in IBB in Q4 2023 and held it in 5 quarters. The position peaked at $93.6K in Q3 2024. 831 funds tracked by Wall St. Rank hold IBB as of Q1 2025.

  • Mitchell Sinkler & Starr reported no remaining iShares Biotechnology ETF position as of Q1 2025 after selling out during the quarter.
  • Mitchell Sinkler & Starr sold 643 iShares Biotechnology ETF shares in Q1 2025, an estimated $85K.
  • Mitchell Sinkler & Starr first reported a position in iShares Biotechnology ETF in Q4 2023 and held it in 5 quarters.
  • Mitchell Sinkler & Starr's iShares Biotechnology ETF position peaked at $93.6K in Q3 2024.
  • 831 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2025.

Based on Mitchell Sinkler & Starr's 13F filing for Q1 2025, filed 7 May 2025.